Key facts
- A surgical robotics firm backed by SoftBank is planning to list on the Hong Kong stock exchange.
- The company's primary goal for the listing is to finance its expansion into mainland China.
- This strategic move is driven by the increasing demand for advanced medical technologies within China.
A surgical robotics company, which has received backing from SoftBank, is reportedly preparing for a listing on the Hong Kong stock exchange. The primary objective behind this planned public offering is to secure the necessary capital to fuel the company's expansion into mainland China.
This strategic move is underpinned by the anticipated growth in demand for sophisticated medical technologies within the Chinese market. By establishing a stronger presence in China, the company aims to tap into a significant and expanding healthcare sector.